| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |